Rebecca J Moon1, Sarah R Crozier2, Elaine M Dennison2, Justin H Davies3, Sian M Robinson2, Hazel M Inskip2, Keith M Godfrey4, Cyrus Cooper5, Nicholas C Harvey4. 1. Medical Research Council Lifecourse Epidemiology Unit, University of Southampton, Southampton General Hospital, Southampton, United Kingdom; Paediatric Endocrinology, University Hospital Southampton National Health Service (NHS) Foundation Trust, Southampton, United Kingdom; 2. Medical Research Council Lifecourse Epidemiology Unit, University of Southampton, Southampton General Hospital, Southampton, United Kingdom; 3. Paediatric Endocrinology, University Hospital Southampton National Health Service (NHS) Foundation Trust, Southampton, United Kingdom; 4. Medical Research Council Lifecourse Epidemiology Unit, University of Southampton, Southampton General Hospital, Southampton, United Kingdom; National Institute for Health Research (NIHR) Southampton Nutrition Biomedical Research Centre, University of Southampton and University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom; and. 5. Medical Research Council Lifecourse Epidemiology Unit, University of Southampton, Southampton General Hospital, Southampton, United Kingdom; National Institute for Health Research (NIHR) Southampton Nutrition Biomedical Research Centre, University of Southampton and University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom; and cc@mrc.soton.ac.uk.
Abstract
BACKGROUND: The role of maternal 25-hydroxyvitamin D [25(OH)D] in fetal development is uncertain, and findings of observational studies have been inconsistent. Most studies have assessed 25(OH)D only one time during pregnancy, but to our knowledge, the tracking of an individual's 25(OH)D during pregnancy has not been assessed previously. OBJECTIVE: We determined the tracking of serum 25(OH)D from early to late pregnancy and factors that influence this. DESIGN: The Southampton Women's Survey is a prospective mother-offspring birth-cohort study. Lifestyle, diet, and 25(OH)D status were assessed at 11 and 34 wk of gestation. A Fourier transformation was used to model the seasonal variation in 25(OH)D for early and late pregnancy separately, and the difference between the measured and seasonally modeled 25(OH)D was calculated to generate a season-corrected 25(OH)D. Tracking was assessed with the use of the Pearson correlation coefficient, and multivariate linear regression was used to determine factors associated with the change in season-corrected 25(OH)D. RESULTS: A total of 1753 women had 25(OH)D measured in both early and late pregnancy. There was a moderate correlation between season-corrected 25(OH)D measurements at 11 and 34 wk of gestation (r = 0.53, P < 0.0001; n = 1753). Vitamin D supplementation was the strongest predictor of tracking; in comparison with women who never used supplements, the discontinuation of supplementation after 11 wk was associated with a reduction in season-corrected 25(OH)D (β = -7.3 nmol/L; P < 0.001), whereas the commencement (β = 12.6 nmol/L; P < 0.001) or continuation (β = 6.6 nmol/L; P < 0.001) of supplementation was associated with increases in season-corrected 25(OH)D. Higher pregnancy weight gain was associated with a reduction in season-corrected 25(OH)D (β = -0.4 nmol · L(-1) · kg(-1); P = 0.015), whereas greater physical activity (β = 0.4 nmol/L per h/wk; P = 0.011) was associated with increases. CONCLUSIONS: There is a moderate tracking of 25(OH)D status through pregnancy; factors such as vitamin D supplementation, weight gain, and physical activity are associated with changes in season-corrected 25(OH)D from early to late gestation. These findings have implications for study designs and analyses and approaches to intervention studies and clinical care.
BACKGROUND: The role of maternal 25-hydroxyvitamin D [25(OH)D] in fetal development is uncertain, and findings of observational studies have been inconsistent. Most studies have assessed 25(OH)D only one time during pregnancy, but to our knowledge, the tracking of an individual's 25(OH)D during pregnancy has not been assessed previously. OBJECTIVE: We determined the tracking of serum 25(OH)D from early to late pregnancy and factors that influence this. DESIGN: The Southampton Women's Survey is a prospective mother-offspring birth-cohort study. Lifestyle, diet, and 25(OH)D status were assessed at 11 and 34 wk of gestation. A Fourier transformation was used to model the seasonal variation in 25(OH)D for early and late pregnancy separately, and the difference between the measured and seasonally modeled 25(OH)D was calculated to generate a season-corrected 25(OH)D. Tracking was assessed with the use of the Pearson correlation coefficient, and multivariate linear regression was used to determine factors associated with the change in season-corrected 25(OH)D. RESULTS: A total of 1753 women had 25(OH)D measured in both early and late pregnancy. There was a moderate correlation between season-corrected 25(OH)D measurements at 11 and 34 wk of gestation (r = 0.53, P < 0.0001; n = 1753). Vitamin D supplementation was the strongest predictor of tracking; in comparison with women who never used supplements, the discontinuation of supplementation after 11 wk was associated with a reduction in season-corrected 25(OH)D (β = -7.3 nmol/L; P < 0.001), whereas the commencement (β = 12.6 nmol/L; P < 0.001) or continuation (β = 6.6 nmol/L; P < 0.001) of supplementation was associated with increases in season-corrected 25(OH)D. Higher pregnancy weight gain was associated with a reduction in season-corrected 25(OH)D (β = -0.4 nmol · L(-1) · kg(-1); P = 0.015), whereas greater physical activity (β = 0.4 nmol/L per h/wk; P = 0.011) was associated with increases. CONCLUSIONS: There is a moderate tracking of 25(OH)D status through pregnancy; factors such as vitamin D supplementation, weight gain, and physical activity are associated with changes in season-corrected 25(OH)D from early to late gestation. These findings have implications for study designs and analyses and approaches to intervention studies and clinical care.
Authors: Jonathan N Hofmann; Kai Yu; Ronald L Horst; Richard B Hayes; Mark P Purdue Journal: Cancer Epidemiol Biomarkers Prev Date: 2010-03-23 Impact factor: 4.254
Authors: Caitlin Mason; Liren Xiao; Ikuyo Imayama; Catherine R Duggan; Carolyn Bain; Karen E Foster-Schubert; Angela Kong; Kristin L Campbell; Ching-Yun Wang; Marian L Neuhouser; Li Li; Robert W Jeffery; Kim Robien; Catherine M Alfano; George L Blackburn; Anne McTiernan Journal: Am J Clin Nutr Date: 2011-05-25 Impact factor: 7.045
Authors: Hazel M Inskip; Keith M Godfrey; Siân M Robinson; Catherine M Law; David J P Barker; Cyrus Cooper Journal: Int J Epidemiol Date: 2005-09-29 Impact factor: 7.196
Authors: Nicholas C Harvey; Christopher Holroyd; Georgia Ntani; Kassim Javaid; Philip Cooper; Rebecca Moon; Zoe Cole; Tannaze Tinati; Keith Godfrey; Elaine Dennison; Nicholas J Bishop; Janis Baird; Cyrus Cooper Journal: Health Technol Assess Date: 2014-07 Impact factor: 4.014
Authors: Zahra Raisi-Estabragh; Celeste McCracken; Mae S Bethell; Jackie Cooper; Cyrus Cooper; Mark J Caulfield; Patricia B Munroe; Nicholas C Harvey; Steffen E Petersen Journal: J Public Health (Oxf) Date: 2020-08-18 Impact factor: 2.341
Authors: Mengdi Lu; Bruce W Hollis; Vincent J Carey; Nancy Laranjo; Ravinder J Singh; Scott T Weiss; Augusto A Litonjua Journal: J Clin Endocrinol Metab Date: 2020-04-01 Impact factor: 5.958
Authors: S Butscheidt; A Delsmann; T Rolvien; F Barvencik; M Al-Bughaili; S Mundlos; T Schinke; M Amling; U Kornak; R Oheim Journal: Osteoporos Int Date: 2018-03-29 Impact factor: 4.507
Authors: Helena H Hauta-Alus; Elisa M Holmlund-Suila; Hannu J Rita; Maria Enlund-Cerullo; Jenni Rosendahl; Saara M Valkama; Otto M Helve; Timo K Hytinantti; Heljä-Marja Surcel; Outi M Mäkitie; Sture Andersson; Heli T Viljakainen Journal: Eur J Nutr Date: 2017-03-02 Impact factor: 5.614
Authors: Rebecca J Moon; Laura D F Cooke; Stefania D'Angelo; Elizabeth M Curtis; Philip Titcombe; Justin H Davies; Keith M Godfrey; Jane K Cleal; Rohan M Lewis; Cyrus Cooper; Nicholas C Harvey Journal: J Clin Endocrinol Metab Date: 2022-07-14 Impact factor: 6.134
Authors: Cristina Palacios; Maria Angelica Trak-Fellermeier; Ricardo X Martinez; Lucero Lopez-Perez; Paul Lips; James A Salisi; Jessica C John; Juan Pablo Peña-Rosas Journal: Cochrane Database Syst Rev Date: 2019-10-03